お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、NAD+増強剤の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にNAD+増強剤市場を分類しています。
本レポートでは世界のNAD+増強剤市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：GeneHarbor、Chromadex、Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)、Herbalmax、EffePharm、Kingdomway、NOMON Co., Ltd. (Teijin)、CELFULL、Bontac、Genex Formulas、EZZ、Maac10 Formulas、Elysium Health

レポートはNAD+増強剤の主要生産者を調査し、主要地域や国の消費状況も提供します。NAD+増強剤の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Content ＜98%
    Content ≥98%

用途別の市場セグメント：
    Health Care Products
    ClinicsBeauty Products
    Others

本レポートの詳細内容
本レポートは、世界のNAD+増強剤市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてNAD+増強剤市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）のNAD+増強剤生産量、成長率、市場シェアを調査している。

二. 消費面では、NAD+増強剤の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーのNAD+増強剤売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のNAD+増強剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本NAD+増強剤のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：NAD+増強剤のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： NAD+増強剤の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおけるNAD+増強剤の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章NAD+増強剤メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：NAD+増強剤の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：NAD+増強剤の主要メーカーの概要を提供し、製品の説明と仕様、NAD+増強剤の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：NAD+増強剤の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme found in all living cells. It plays a crucial role in various biological processes, including energy metabolism, DNA repair, and gene expression. Some people are interested in NAD+ enhancers, which are substances or compounds that may support or increase the levels of NAD+ in the body.
The global NAD+ Enhancer market is projected to grow from US$ 507 million in 2024 to US$ 1183 million by 2030, at a Compound Annual Growth Rate (CAGR) of 15.2% during the forecast period.
For the NAD+ Enhancer industry, the market is high concentrated. GeneHarbor, Chromade and MIRAILAB BIOSCIENCE (Shinkowa Pharmaceutical) are the leading companies globally. The Top 5 players listed in the report accounted for about 41% of the market. There are several types of NAD+ Enhancer. The market can be segmented into, Content ＜98%, Content ≥98%. Content ≥98% are the most commonly used type, accounting for 93% of the market share in 2022. By application, Health Care Products are the largest downstream application area, with a consumption market share of 84% in 2022.
Report Includes
This report presents an overview of global market for NAD+ Enhancer, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of NAD+ Enhancer, also provides the sales of main regions and countries. Highlights of the upcoming market potential for NAD+ Enhancer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the NAD+ Enhancer sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global NAD+ Enhancer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for NAD+ Enhancer sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including GeneHarbor, Chromadex, Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), Herbalmax, EffePharm, Kingdomway, NOMON Co., Ltd. (Teijin), CELFULL, Bontac, Genex Formulas, etc.
Market Segmentation
By Company
    GeneHarbor
    Chromadex
    Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
    Herbalmax
    EffePharm
    Kingdomway
    NOMON Co., Ltd. (Teijin)
    CELFULL
    Bontac
    Genex Formulas
    EZZ
    Maac10 Formulas
    Elysium Health

Segment by Type
    Content ＜98%
    Content ≥98%

Segment by Application
    Health Care Products
    ClinicsBeauty Products
    Others

Segment by region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of NAD+ Enhancer in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of NAD+ Enhancer manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NAD+ Enhancer sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
 Table 1. Global NAD+ Enhancer Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Table 2. Major Manufacturers of Content ＜98%
 Table 3. Major Manufacturers of Content ≥98%
 Table 4. Global NAD+ Enhancer Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Table 5. Global NAD+ Enhancer Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 6. Global NAD+ Enhancer Revenue by Region (2019-2024) & (US$ Million)
 Table 7. Global NAD+ Enhancer Revenue by Region (2025-2030) & (US$ Million)
 Table 8. Global NAD+ Enhancer Revenue Market Share by Region (2019-2024)
 Table 9. Global NAD+ Enhancer Revenue Market Share by Region (2025-2030)
 Table 10. Global NAD+ Enhancer Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
 Table 11. Global NAD+ Enhancer Sales by Region (2019-2024) & (K Units)
 Table 12. Global NAD+ Enhancer Sales by Region (2025-2030) & (K Units)
 Table 13. Global NAD+ Enhancer Sales Market Share by Region (2019-2024)
 Table 14. Global NAD+ Enhancer Sales Market Share by Region (2025-2030)
 Table 15. Global NAD+ Enhancer Sales by Manufacturers (2019-2024) & (K Units)
 Table 16. Global NAD+ Enhancer Sales Share by Manufacturers (2019-2024)
 Table 17. Global NAD+ Enhancer Revenue by Manufacturers (2019-2024) & (US$ Million)
 Table 18. Global NAD+ Enhancer Revenue Market Share by Manufacturers (2019-2024)
 Table 19. Global Key Players of NAD+ Enhancer, Industry Ranking, 2021 VS 2022 VS 2023
 Table 20. NAD+ Enhancer Price by Manufacturers (2019-2024) & (US$/Unit)
 Table 21. Global NAD+ Enhancer Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 22. Global NAD+ Enhancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NAD+ Enhancer as of 2023)
 Table 23. Global Key Manufacturers of NAD+ Enhancer, Manufacturing Base Distribution and Headquarters
 Table 24. Global Key Manufacturers of NAD+ Enhancer, Product Offered and Application
 Table 25. Global Key Manufacturers of NAD+ Enhancer, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global NAD+ Enhancer Sales by Type (2019-2024) & (K Units)
 Table 28. Global NAD+ Enhancer Sales by Type (2025-2030) & (K Units)
 Table 29. Global NAD+ Enhancer Sales Share by Type (2019-2024)
 Table 30. Global NAD+ Enhancer Sales Share by Type (2025-2030)
 Table 31. Global NAD+ Enhancer Revenue by Type (2019-2024) & (US$ Million)
 Table 32. Global NAD+ Enhancer Revenue by Type (2025-2030) & (US$ Million)
 Table 33. Global NAD+ Enhancer Revenue Share by Type (2019-2024)
 Table 34. Global NAD+ Enhancer Revenue Share by Type (2025-2030)
 Table 35. NAD+ Enhancer Price by Type (2019-2024) & (US$/Unit)
 Table 36. Global NAD+ Enhancer Price Forecast by Type (2025-2030) & (US$/Unit)
 Table 37. Global NAD+ Enhancer Sales by Application (2019-2024) & (K Units)
 Table 38. Global NAD+ Enhancer Sales by Application (2025-2030) & (K Units)
 Table 39. Global NAD+ Enhancer Sales Share by Application (2019-2024)
 Table 40. Global NAD+ Enhancer Sales Share by Application (2025-2030)
 Table 41. Global NAD+ Enhancer Revenue by Application (2019-2024) & (US$ Million)
 Table 42. Global NAD+ Enhancer Revenue by Application (2025-2030) & (US$ Million)
 Table 43. Global NAD+ Enhancer Revenue Share by Application (2019-2024)
 Table 44. Global NAD+ Enhancer Revenue Share by Application (2025-2030)
 Table 45. NAD+ Enhancer Price by Application (2019-2024) & (US$/Unit)
 Table 46. Global NAD+ Enhancer Price Forecast by Application (2025-2030) & (US$/Unit)
 Table 47. US & Canada NAD+ Enhancer Sales by Type (2019-2024) & (K Units)
 Table 48. US & Canada NAD+ Enhancer Sales by Type (2025-2030) & (K Units)
 Table 49. US & Canada NAD+ Enhancer Revenue by Type (2019-2024) & (US$ Million)
 Table 50. US & Canada NAD+ Enhancer Revenue by Type (2025-2030) & (US$ Million)
 Table 51. US & Canada NAD+ Enhancer Sales by Application (2019-2024) & (K Units)
 Table 52. US & Canada NAD+ Enhancer Sales by Application (2025-2030) & (K Units)
 Table 53. US & Canada NAD+ Enhancer Revenue by Application (2019-2024) & (US$ Million)
 Table 54. US & Canada NAD+ Enhancer Revenue by Application (2025-2030) & (US$ Million)
 Table 55. US & Canada NAD+ Enhancer Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 56. US & Canada NAD+ Enhancer Revenue by Country (2019-2024) & (US$ Million)
 Table 57. US & Canada NAD+ Enhancer Revenue by Country (2025-2030) & (US$ Million)
 Table 58. US & Canada NAD+ Enhancer Sales by Country (2019-2024) & (K Units)
 Table 59. US & Canada NAD+ Enhancer Sales by Country (2025-2030) & (K Units)
 Table 60. Europe NAD+ Enhancer Sales by Type (2019-2024) & (K Units)
 Table 61. Europe NAD+ Enhancer Sales by Type (2025-2030) & (K Units)
 Table 62. Europe NAD+ Enhancer Revenue by Type (2019-2024) & (US$ Million)
 Table 63. Europe NAD+ Enhancer Revenue by Type (2025-2030) & (US$ Million)
 Table 64. Europe NAD+ Enhancer Sales by Application (2019-2024) & (K Units)
 Table 65. Europe NAD+ Enhancer Sales by Application (2025-2030) & (K Units)
 Table 66. Europe NAD+ Enhancer Revenue by Application (2019-2024) & (US$ Million)
 Table 67. Europe NAD+ Enhancer Revenue by Application (2025-2030) & (US$ Million)
 Table 68. Europe NAD+ Enhancer Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 69. Europe NAD+ Enhancer Revenue by Country (2019-2024) & (US$ Million)
 Table 70. Europe NAD+ Enhancer Revenue by Country (2025-2030) & (US$ Million)
 Table 71. Europe NAD+ Enhancer Sales by Country (2019-2024) & (K Units)
 Table 72. Europe NAD+ Enhancer Sales by Country (2025-2030) & (K Units)
 Table 73. China NAD+ Enhancer Sales by Type (2019-2024) & (K Units)
 Table 74. China NAD+ Enhancer Sales by Type (2025-2030) & (K Units)
 Table 75. China NAD+ Enhancer Revenue by Type (2019-2024) & (US$ Million)
 Table 76. China NAD+ Enhancer Revenue by Type (2025-2030) & (US$ Million)
 Table 77. China NAD+ Enhancer Sales by Application (2019-2024) & (K Units)
 Table 78. China NAD+ Enhancer Sales by Application (2025-2030) & (K Units)
 Table 79. China NAD+ Enhancer Revenue by Application (2019-2024) & (US$ Million)
 Table 80. China NAD+ Enhancer Revenue by Application (2025-2030) & (US$ Million)
 Table 81. Asia NAD+ Enhancer Sales by Type (2019-2024) & (K Units)
 Table 82. Asia NAD+ Enhancer Sales by Type (2025-2030) & (K Units)
 Table 83. Asia NAD+ Enhancer Revenue by Type (2019-2024) & (US$ Million)
 Table 84. Asia NAD+ Enhancer Revenue by Type (2025-2030) & (US$ Million)
 Table 85. Asia NAD+ Enhancer Sales by Application (2019-2024) & (K Units)
 Table 86. Asia NAD+ Enhancer Sales by Application (2025-2030) & (K Units)
 Table 87. Asia NAD+ Enhancer Revenue by Application (2019-2024) & (US$ Million)
 Table 88. Asia NAD+ Enhancer Revenue by Application (2025-2030) & (US$ Million)
 Table 89. Asia NAD+ Enhancer Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 90. Asia NAD+ Enhancer Revenue by Region (2019-2024) & (US$ Million)
 Table 91. Asia NAD+ Enhancer Revenue by Region (2025-2030) & (US$ Million)
 Table 92. Asia NAD+ Enhancer Sales by Region (2019-2024) & (K Units)
 Table 93. Asia NAD+ Enhancer Sales by Region (2025-2030) & (K Units)
 Table 94. Middle East, Africa and Latin America NAD+ Enhancer Sales by Type (2019-2024) & (K Units)
 Table 95. Middle East, Africa and Latin America NAD+ Enhancer Sales by Type (2025-2030) & (K Units)
 Table 96. Middle East, Africa and Latin America NAD+ Enhancer Revenue by Type (2019-2024) & (US$ Million)
 Table 97. Middle East, Africa and Latin America NAD+ Enhancer Revenue by Type (2025-2030) & (US$ Million)
 Table 98. Middle East, Africa and Latin America NAD+ Enhancer Sales by Application (2019-2024) & (K Units)
 Table 99. Middle East, Africa and Latin America NAD+ Enhancer Sales by Application (2025-2030) & (K Units)
 Table 100. Middle East, Africa and Latin America NAD+ Enhancer Revenue by Application (2019-2024) & (US$ Million)
 Table 101. Middle East, Africa and Latin America NAD+ Enhancer Revenue by Application (2025-2030) & (US$ Million)
 Table 102. Middle East, Africa and Latin America NAD+ Enhancer Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 103. Middle East, Africa and Latin America NAD+ Enhancer Revenue by Country (2019-2024) & (US$ Million)
 Table 104. Middle East, Africa and Latin America NAD+ Enhancer Revenue by Country (2025-2030) & (US$ Million)
 Table 105. Middle East, Africa and Latin America NAD+ Enhancer Sales by Country (2019-2024) & (K Units)
 Table 106. Middle East, Africa and Latin America NAD+ Enhancer Sales by Country (2025-2030) & (K Units)
 Table 107. GeneHarbor Company Information
 Table 108. GeneHarbor Description and Major Businesses
 Table 109. GeneHarbor NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 110. GeneHarbor NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 111. GeneHarbor Recent Developments
 Table 112. Chromadex Company Information
 Table 113. Chromadex Description and Major Businesses
 Table 114. Chromadex NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 115. Chromadex NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 116. Chromadex Recent Developments
 Table 117. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information
 Table 118. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Description and Major Businesses
 Table 119. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 120. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 121. Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments
 Table 122. Herbalmax Company Information
 Table 123. Herbalmax Description and Major Businesses
 Table 124. Herbalmax NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 125. Herbalmax NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 126. Herbalmax Recent Developments
 Table 127. EffePharm Company Information
 Table 128. EffePharm Description and Major Businesses
 Table 129. EffePharm NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 130. EffePharm NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 131. EffePharm Recent Developments
 Table 132. Kingdomway Company Information
 Table 133. Kingdomway Description and Major Businesses
 Table 134. Kingdomway NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 135. Kingdomway NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 136. Kingdomway Recent Developments
 Table 137. NOMON Co., Ltd. (Teijin) Company Information
 Table 138. NOMON Co., Ltd. (Teijin) Description and Major Businesses
 Table 139. NOMON Co., Ltd. (Teijin) NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 140. NOMON Co., Ltd. (Teijin) NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 141. NOMON Co., Ltd. (Teijin) Recent Developments
 Table 142. CELFULL Company Information
 Table 143. CELFULL Description and Major Businesses
 Table 144. CELFULL NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 145. CELFULL NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 146. CELFULL Recent Developments
 Table 147. Bontac Company Information
 Table 148. Bontac Description and Major Businesses
 Table 149. Bontac NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 150. Bontac NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 151. Bontac Recent Developments
 Table 152. Genex Formulas Company Information
 Table 153. Genex Formulas Description and Major Businesses
 Table 154. Genex Formulas NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 155. Genex Formulas NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 156. Genex Formulas Recent Developments
 Table 157. EZZ Company Information
 Table 158. EZZ Description and Major Businesses
 Table 159. EZZ NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 160. EZZ NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 161. EZZ Recent Developments
 Table 162. Maac10 Formulas Company Information
 Table 163. Maac10 Formulas Description and Major Businesses
 Table 164. Maac10 Formulas NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 165. Maac10 Formulas NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 166. Maac10 Formulas Recent Developments
 Table 167. Elysium Health Company Information
 Table 168. Elysium Health Description and Major Businesses
 Table 169. Elysium Health NAD+ Enhancer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 170. Elysium Health NAD+ Enhancer Product Model Numbers, Pictures, Descriptions and Specifications
 Table 171. Elysium Health Recent Developments
 Table 172. Key Raw Materials Lists
 Table 173. Raw Materials Key Suppliers Lists
 Table 174. NAD+ Enhancer Distributors List
 Table 175. NAD+ Enhancer Customers List
 Table 176. NAD+ Enhancer Market Trends
 Table 177. NAD+ Enhancer Market Drivers
 Table 178. NAD+ Enhancer Market Challenges
 Table 179. NAD+ Enhancer Market Restraints
 Table 180. Research Programs/Design for This Report
 Table 181. Key Data Information from Secondary Sources
 Table 182. Key Data Information from Primary Sources


List of Figures
 Figure 1. NAD+ Enhancer Product Picture
 Figure 2. Global NAD+ Enhancer Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global NAD+ Enhancer Market Share by Type: 2023 & 2030
 Figure 4. Content ＜98% Product Picture
 Figure 5. Content ≥98% Product Picture
 Figure 6. Global NAD+ Enhancer Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 7. Global NAD+ Enhancer Market Share by Application: 2023 & 2030
 Figure 8. Health Care Products
 Figure 9. ClinicsBeauty Products
 Figure 10. Others
 Figure 11. NAD+ Enhancer Report Years Considered
 Figure 12. Global NAD+ Enhancer Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 14. Global NAD+ Enhancer Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Figure 15. Global NAD+ Enhancer Revenue Market Share by Region in Percentage: 2023 Versus 2030
 Figure 16. Global NAD+ Enhancer Revenue Market Share by Region (2019-2030)
 Figure 17. Global NAD+ Enhancer Sales (2019-2030) & (K Units)
 Figure 18. Global NAD+ Enhancer Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
 Figure 19. Global NAD+ Enhancer Sales Market Share by Region (2019-2030)
 Figure 20. US & Canada NAD+ Enhancer Sales YoY (2019-2030) & (K Units)
 Figure 21. US & Canada NAD+ Enhancer Revenue YoY (2019-2030) & (US$ Million)
 Figure 22. Europe NAD+ Enhancer Sales YoY (2019-2030) & (K Units)
 Figure 23. Europe NAD+ Enhancer Revenue YoY (2019-2030) & (US$ Million)
 Figure 24. China NAD+ Enhancer Sales YoY (2019-2030) & (K Units)
 Figure 25. China NAD+ Enhancer Revenue YoY (2019-2030) & (US$ Million)
 Figure 26. Asia (excluding China) NAD+ Enhancer Sales YoY (2019-2030) & (K Units)
 Figure 27. Asia (excluding China) NAD+ Enhancer Revenue YoY (2019-2030) & (US$ Million)
 Figure 28. Middle East, Africa and Latin America NAD+ Enhancer Sales YoY (2019-2030) & (K Units)
 Figure 29. Middle East, Africa and Latin America NAD+ Enhancer Revenue YoY (2019-2030) & (US$ Million)
 Figure 30. Global NAD+ Enhancer Sales Share by Manufacturers (2023)
 Figure 31. The NAD+ Enhancer Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
 Figure 32. Global NAD+ Enhancer Revenue Share by Manufacturers (2023)
 Figure 33. The Top 5 and 10 Largest Manufacturers of NAD+ Enhancer in the World: Market Share by NAD+ Enhancer Revenue in 2023
 Figure 34. Global NAD+ Enhancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 35. Global NAD+ Enhancer Sales Market Share by Type (2019-2030)
 Figure 36. Global NAD+ Enhancer Revenue Market Share by Type (2019-2030)
 Figure 37. Global NAD+ Enhancer Sales Market Share by Application (2019-2030)
 Figure 38. Global NAD+ Enhancer Revenue Market Share by Application (2019-2030)
 Figure 39. US & Canada NAD+ Enhancer Sales Market Share by Type (2019-2030)
 Figure 40. US & Canada NAD+ Enhancer Revenue Market Share by Type (2019-2030)
 Figure 41. US & Canada NAD+ Enhancer Sales Market Share by Application (2019-2030)
 Figure 42. US & Canada NAD+ Enhancer Revenue Market Share by Application (2019-2030)
 Figure 43. US & Canada NAD+ Enhancer Revenue Share by Country (2019-2030)
 Figure 44. US & Canada NAD+ Enhancer Sales Share by Country (2019-2030)
 Figure 45. US NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 46. Canada NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 47. Europe NAD+ Enhancer Sales Market Share by Type (2019-2030)
 Figure 48. Europe NAD+ Enhancer Revenue Market Share by Type (2019-2030)
 Figure 49. Europe NAD+ Enhancer Sales Market Share by Application (2019-2030)
 Figure 50. Europe NAD+ Enhancer Revenue Market Share by Application (2019-2030)
 Figure 51. Europe NAD+ Enhancer Revenue Share by Country (2019-2030)
 Figure 52. Europe NAD+ Enhancer Sales Share by Country (2019-2030)
 Figure 53. Germany NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 54. France NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 55. U.K. NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 56. Italy NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 57. Russia NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 58. China NAD+ Enhancer Sales Market Share by Type (2019-2030)
 Figure 59. China NAD+ Enhancer Revenue Market Share by Type (2019-2030)
 Figure 60. China NAD+ Enhancer Sales Market Share by Application (2019-2030)
 Figure 61. China NAD+ Enhancer Revenue Market Share by Application (2019-2030)
 Figure 62. Asia NAD+ Enhancer Sales Market Share by Type (2019-2030)
 Figure 63. Asia NAD+ Enhancer Revenue Market Share by Type (2019-2030)
 Figure 64. Asia NAD+ Enhancer Sales Market Share by Application (2019-2030)
 Figure 65. Asia NAD+ Enhancer Revenue Market Share by Application (2019-2030)
 Figure 66. Asia NAD+ Enhancer Revenue Share by Region (2019-2030)
 Figure 67. Asia NAD+ Enhancer Sales Share by Region (2019-2030)
 Figure 68. Japan NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 69. South Korea NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 70. China Taiwan NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 71. Southeast Asia NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 72. India NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 73. Australia NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 74. Middle East, Africa and Latin America NAD+ Enhancer Sales Market Share by Type (2019-2030)
 Figure 75. Middle East, Africa and Latin America NAD+ Enhancer Revenue Market Share by Type (2019-2030)
 Figure 76. Middle East, Africa and Latin America NAD+ Enhancer Sales Market Share by Application (2019-2030)
 Figure 77. Middle East, Africa and Latin America NAD+ Enhancer Revenue Market Share by Application (2019-2030)
 Figure 78. Middle East, Africa and Latin America NAD+ Enhancer Revenue Share by Country (2019-2030)
 Figure 79. Middle East, Africa and Latin America NAD+ Enhancer Sales Share by Country (2019-2030)
 Figure 80. Brazil NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 81. Mexico NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 82. Turkey NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 83. Israel NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 84. GCC Countries NAD+ Enhancer Revenue (2019-2030) & (US$ Million)
 Figure 85. NAD+ Enhancer Value Chain
 Figure 86. NAD+ Enhancer Production Process
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed